Amgen is finally making an expected splash out of its cash pile, but questions are abounding about the cost paid for Celgene's Otezla.
General Electric's CEO isn't inspiring much confidence.
KHC has a big problem on its balance sheet.
Where China needs to defend the renminbi from falling too far.
If money's already tight, long-term rates may have already peaked.
From overweighting dividend stocks to avoiding high-yield bonds, this is how I'm playing things here.
A bearishly biased out-of-the-money long put 'shooter' expiring in January.
A road trip reveals some surprising answers.
Watch our video and get to know your new Fed Chair.
President Trump's tax cuts will push U.S. debt much higher, Scope Ratings warns.